IPO

Securus Monitoring touts high-tech supervision tools for modern reentry, but its parent company's controversial history casts a long shadow over its promises.

Once a failing firm, Aurelion Inc. bet its future on tokenized gold. The gamble paid off with a profitable quarter, but regulatory risks loom large.

After a strong Q4, Amprius launches a strategic roadshow to pitch its high-energy silicon anode batteries to investors and key aerospace and defense players.

Phoenix innovator GACW proves its steel Air Suspension Wheel in brutal -40°F mining tests, paving the way for a safer, non-pneumatic 2026 commercial release.

With $65M in new funding and a new CEO, Duos is betting big on a $200M NVIDIA GPU deal to become a key player in the booming Edge AI infrastructure market.

With a soaring stock and a breakthrough CAR-T therapy, Immix Biopharma is set to capture investor attention. What's behind the hype for its lead drug, NXC-201?

New analytics in the duPont REGISTRY Garage app bring Wall Street-style charts to car collecting, empowering owners to trade passion assets like stocks.

China's tropical city of Sanya is leveraging radical 'Seventh Air Freedom' policies to build a new tourism and aviation network linking Europe and Central Asia.

Daxor reports a transformative year with 45% revenue growth, a new FDA-cleared portable analyzer, and a full pivot to a high-growth medtech company.

A new AI tool clarifies accented English for listeners in real time, sparking both excitement for global business and debate over cultural identity.

As Uni-Fuels blankets Thailand with bunkering services, the move highlights the nation's rising maritime importance and the intense battle for market share.

A new partnership uses AI and real-time payments to slash financial risk, unlock capital, and turn energy-hungry industries into powerful grid allies.

With a new focus and fresh capital, Trigon Metals begins a key drilling campaign at its Addana project, betting on Moroccan silver to power the future.

With promising clinical data for its heart disease treatments, Lexeo Therapeutics aims to capture investor attention at the upcoming Leerink conference.

After a kidney trial setback, CalciMedica's lead drug Auxora shows strong promise for acute pancreatitis, but a tight cash runway looms over its future.

Post-listing, the Swiss HealthTech firm pushes for US market expansion and European reimbursement, streamlining its focus on AI-powered brain health.

Riot Platforms reports a record $647M revenue for 2025, but a staggering net loss and a strategic pivot to data centers raises critical questions.

Entrepreneur Daniel Gestetner discusses resilience, a $1B exit, and why true success isn't about winning at all costs in a revealing new podcast.

Cuentas and Hallo 015 launch a unique MVNO service, blending mobile connectivity and exclusive content for the growing Israeli community in the United States.

With a new unified command under mining veteran Mark Wall, American Rare Earths aims to accelerate its massive Halleck Creek project and secure the U.S. supply chain.